Evidence map›Paper›PMID 37242791›Full record

ReviewPharmaceutics2023

Catestatin: Antimicrobial Functions and Potential Therapeutics.

Suborno Jati, Sumana Mahata, Soumita Das, Saurabh Chatterjee, Sushil K Mahata

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Suborno JatiDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Sumana MahataDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Soumita DasDepartment of Biomedical and Nutritional Science, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Saurabh ChatterjeeDepartment of Medicine, University of California Irvine, Irvine, CA 92697, USA.ORCID 0000-0003-1649-7149
Sushil K MahataDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
University of California San Diego · USUniversity of Massachusetts Lowell · USUniversity of California, Irvine · US

Funding

The Role of Chromogranin A in TauopathyR21AG072487 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, XU, GHOSH, GOURISANKAR · 2021 to 2021
$434k
Peptide therapy for age-associated gut dysmotilityR21AG080246 · NIA · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI MAHATA, SUSHIL K · 2023 to 2024
$399k
NIA NIH HHS R21 AG072487NIA NIH HHS R21 AG080246NIH HHS 1 R21 AG072487-01 and 1 R21 AG080246-01 to S.K.M.
6 · The paper itself

Abstract

The rapid increase in drug-resistant and multidrug-resistant infections poses a serious challenge to antimicrobial therapies, and has created a global health crisis. Since antimicrobial peptides (AMPs) have escaped bacterial resistance throughout evolution, AMPs are a category of potential alternatives for antibiotic-resistant "superbugs". The Chromogranin A (CgA)-derived peptide Catestatin (CST: hCgA

Indexed as

antimicrobial peptidecatestatincell permeable peptideChromogranin Agut microbiome

Identifiers

PMID37242791
PMCPMC10220906
OpenAlexW4377293970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.